FDA Fast-Tracks New Cancer Drug for Skin Cancer While Cannabis Science Inc. Offers Topical Treatment for Basal Cell Carcinoma with No Apparent Side Effects

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to inform that news of recent FDA Cancer Drug Approval puts Cannabis Science in a very good position moving forward with its current Cancer solutions.